Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LUMINOUS: Study to Observe the Effectiveness and Safety of Ranibizumab Through Individualized Patient Treatment and Associated Outcomes

NCT01318941 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT01318941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01318941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LUMINOUS: Study to Observe the Effectiveness and Safety of Ranibizumab Through Individualized Patient Treatment and Associated Outcomes
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
April 30, 2016
Enrollment
30,490 (actual)
Sites
463

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, retinal vein occlusion, wet age related macular degeneration, wet age related macular degeneration, diabetic macular edema, retinal vein occlusion